Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.

Fabio Salvatore Macaluso,Marcello Maida,Sara Renna,Emanuele Orlando,Marco Affronti,Chiara Sapienza,Mariangela Dimarco,Rosalba Orlando,Giulia Rizzuto,Mario Cottone,Ambrogio Orlando

Digestive and Liver Disease（2017）

引用 5|浏览14

暂无评分

摘要

This is the first experience reporting a clinical benefit and tolerability of mycophenolate mofetil in patients with inflammatory bowel disease and multiple previous failures to other immunosuppressants and/or biologics.

查看译文

关键词

Biologics,Crohn’s disease,Immunosuppressants,Ulcerative colitis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要